CTI Plans To Spin Off Systems Medicine As Pharmacogenomics Company Apana
This article was originally published in The Pink Sheet Daily
Executive Summary
New firm’s management team is looking for pharma partners to validate its expertise, attract venture funding while parent CTI struggles to stay in business.